Decoy Therapeutics DCOY
NASDAQ DCOY
$1.77 -0.09 (-4.58%)
At close: Oct 2, 2026 · 4:00 PM EDT

Decoy Therapeutics (DCOY) Selling, General & Administrative (2015 - 2026)

Updated

Decoy Therapeutics (DCOY) posted Selling, General & Administrative of $1.33 million for Q2 2026, up 56.2% from $849,182 a year earlier but down 13.5% from the prior quarter.

Analysis

Decoy Therapeutics (DCOY) Selling, General & Administrative (2015 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Decoy Therapeutics was $4.1 million, down 12.4% year-over-year; for FY2025, it was $3.73 million, down 24.9% from FY2024.

  • Annual Selling, General & Administrative has declined for three consecutive years, with a five-year compound annual growth rate of -9.4% (FY2020 to FY2025).
  • In prior years, Decoy Therapeutics' Selling, General & Administrative was $4.96 million in FY2024 (-13.2%), $5.72 million in FY2023 (-19.9%), $7.14 million in FY2022 (+16.9%) and $6.1 million in FY2021 (unchanged).
  • Quarterly Selling, General & Administrative has run from a low of $402,167 in Q4 2025 to a high of $1.84 million in Q2 2022 over five years.
  • On a year-over-year basis, Selling, General & Administrative increased in three of the last eight quarters, with an average decline of 5.8%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2026, with growth of 56.2%; the weakest was Q4 2025, with a decline of 69.4%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $1.53 million (Q1 2026), $402,167 (Q4 2025) and $833,304 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Decoy Therapeutics 989,460.49 989,460.49 - 1.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.33 Mn
Mar 31, 2026 1.53 Mn
Dec 31, 2025 402,167.00
Sep 30, 2025 833,304.00
Jun 30, 2025 849,182.00
Mar 31, 2025 1.64 Mn
Dec 31, 2024 1.31 Mn
Sep 30, 2024 869,237.00
Jun 30, 2024 1.25 Mn
Mar 31, 2024 1.53 Mn
Dec 31, 2023 910,748.00
Sep 30, 2023 1.50 Mn
Jun 30, 2023 1.62 Mn
Mar 31, 2023 1.70 Mn
Dec 31, 2022 1.79 Mn
Sep 30, 2022 1.83 Mn
Jun 30, 2022 1.84 Mn
Mar 31, 2022 1.68 Mn
Dec 31, 2021 1.45 Mn
Sep 30, 2021 1.73 Mn
API Access

Decoy Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DCOY&period=max&api_key=YOUR_API_KEY